Skip to main content
Watch Insiders

Corporate insider profile

Kush Parmar Insider Trades

Latest reported as Corporate insider of Skye Bioscience, Inc. (SKYE).

Purchase filings
0
Reported companies
2
Net open-market value
-$2,330,566.67
Latest transaction
Sep 23, 2026

Affiliated corporations

Reported company relationships

SKYELatest reported

Skye Bioscience, Inc.

Corporate insider

TRDAPrior filing

Entrada Therapeutics, Inc.

Director

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 23, 2026Skye Bioscience, Inc. (SKYE)Corporate insiderSale148,079$1.62$239,562
Sep 16, 2026Skye Bioscience, Inc. (SKYE)Corporate insiderSale33,892$1.91$64,734
Aug 20, 2026Skye Bioscience, Inc. (SKYE)Corporate insiderSale375,840$0.37$140,301
Aug 10, 2026Entrada Therapeutics, Inc. (TRDA)DirectorSale155,255$6.95$1,078,945
Jul 31, 2026Entrada Therapeutics, Inc. (TRDA)Director / 10% OwnerSale116,474$6.93$807,025